CN Stock MarketDetailed Quotes

300497 Jiangxi Fushine Pharmaceutical

Watchlist
  • 8.93
  • +0.04+0.45%
Market Closed Jun 28 15:00 CST
4.91BMarket Cap-28993P/E (TTM)

Jiangxi Fushine Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-14.45%340.43M
-2.28%1.61B
4.40%1.29B
2.95%855.65M
-1.10%397.92M
15.23%1.65B
15.59%1.23B
7.13%831.15M
1.82%402.33M
-4.25%1.43B
Operating revenue
-14.45%340.43M
-2.28%1.61B
4.40%1.29B
2.95%855.65M
-1.10%397.92M
15.23%1.65B
15.59%1.23B
7.13%831.15M
1.82%402.33M
-4.25%1.43B
Other operating revenue
----
-13.19%12.39M
----
3.03%10.29M
----
-65.31%14.28M
----
-72.06%9.99M
----
1,459.52%41.15M
Total operating cost
-19.35%347.98M
9.24%1.77B
14.28%1.36B
15.84%914.72M
15.75%431.47M
28.38%1.62B
32.09%1.19B
28.98%789.64M
20.25%372.75M
11.57%1.27B
Operating cost
-18.89%288.91M
6.55%1.44B
14.27%1.14B
16.50%772.72M
17.29%356.2M
35.89%1.35B
37.61%999.14M
32.00%663.3M
20.40%303.68M
11.73%993.55M
Operating tax surcharges
44.28%4.78M
9.33%16.66M
1.99%11.45M
-17.47%6.68M
-19.08%3.32M
4.47%15.23M
-4.07%11.23M
3.55%8.1M
0.64%4.1M
-2.49%14.58M
Operating expense
-73.79%2.36M
3.30%35.34M
14.77%29.18M
43.73%19.61M
16.37%8.99M
-0.83%34.21M
16.67%25.42M
7.33%13.64M
-0.52%7.72M
65.54%34.5M
Administration expense
-10.10%29.33M
8.85%160.32M
-8.28%102.91M
-9.09%68.81M
-11.09%32.62M
12.68%147.28M
26.91%112.2M
45.74%75.69M
35.38%36.69M
26.07%130.7M
Financial expense
-38.09%6.73M
12,304.42%25.88M
259.68%15.69M
210.08%7.27M
187.22%10.87M
-101.60%-212.09K
-373.87%-9.83M
-368.43%-6.6M
4,744.50%3.78M
-53.76%13.25M
-Interest expense (Financial expense)
5.69%10.81M
2.27%42.03M
4.92%31.54M
12.29%20.77M
64.96%10.22M
64.92%41.1M
79.91%30.06M
68.62%18.5M
11.01%6.2M
4.98%24.92M
-Interest Income (Financial expense)
5.34%-2.34M
60.10%-9.29M
64.84%-6.8M
70.06%-4.6M
-19.45%-2.47M
-42.06%-23.29M
-38.21%-19.35M
-56.03%-15.36M
48.69%-2.07M
-11.71%-16.4M
Research and development
-18.50%15.87M
25.83%97.45M
13.81%63.5M
11.61%39.64M
16.11%19.48M
-1.35%77.45M
6.70%55.8M
2.04%35.52M
-11.29%16.77M
2.59%78.51M
Credit Impairment Loss
41.28%-443.85K
-24.68%-4.37M
-73.89%-6.2M
-43.52%-4.15M
83.24%-755.81K
-16.17%-3.51M
-621.56%-3.57M
-8.85%-2.89M
-51.73%-4.51M
5.75%-3.02M
Asset Impairment Loss
----
39.69%-51.76M
-25.54%-1.85M
-78.43%-3.37M
----
-9,477.94%-85.83M
-11,648,121.07%-1.48M
---1.89M
----
-3,790.90%-896.14K
Other net revenue
4,839.37%11.65M
58.76%-64.79M
-222.80%-8.04M
-354.49%-8.81M
75.54%-245.88K
-46.22%-157.09M
-64.63%6.55M
-74.13%3.46M
-127.50%-1.01M
-484.56%-107.44M
Fair value change income
----
100.83%659.37K
91.15%-92.58K
-131.46%-1.93M
-58.89%-1.2M
4.82%-79.25M
-162.34%-1.05M
-162.35%-832.39K
-156.25%-753.5K
-6,477.73%-83.26M
Invest income
-83.38%110.65K
-338.96%-16.16M
-806.75%-4.35M
-1,390.71%-3.02M
-19.66%665.89K
92.45%-3.68M
91.61%-480.21K
105.38%233.66K
149.66%828.79K
-240.94%-48.73M
-Including: Investment income associates
----
-344.60%-14.23M
-252.93%-2.48M
-252.93%-2.48M
----
93.81%-3.2M
---701.95K
80.33%-701.95K
----
-243.05%-51.75M
Asset deal income
----
-81.32%76.3K
-125.00%-7.09K
-125.00%-7.09K
-125.00%-7.09K
795.43%408.35K
148.30%28.36K
-39.99%28.36K
7.85%28.36K
-105.78%-58.72K
Other revenue
1,043.28%11.99M
-54.16%6.77M
-65.87%4.47M
-58.47%3.66M
-69.18%1.05M
-48.25%14.76M
-43.36%13.09M
-53.63%8.81M
-50.93%3.4M
-37.58%28.53M
Operating profit
112.14%4.1M
-71.24%-229.39M
-292.12%-86.07M
-250.96%-67.89M
-218.29%-33.8M
-334.99%-133.95M
-75.20%44.8M
-74.59%44.97M
-67.82%28.58M
-85.27%57M
Add:Non operating Income
-74.87%77.13K
64.43%918.63K
72.61%768.24K
47.03%537.52K
405.54%307K
188.53%558.66K
164.39%445.09K
265.80%365.58K
130.65%60.73K
-94.20%193.62K
Less:Non operating expense
317.08%350.9K
-49.52%4.7M
0.44%1.43M
-58.64%551.28K
-74.55%84.13K
337.30%9.31M
6.06%1.42M
62.99%1.33M
36.63%330.54K
-81.52%2.13M
Total profit
111.40%3.83M
-63.39%-233.17M
-297.90%-86.73M
-254.31%-67.9M
-218.63%-33.58M
-359.15%-142.71M
-75.58%43.82M
-75.04%44M
-68.05%28.31M
-85.46%55.07M
Less:Income tax cost
40,276.92%4.57M
-146.19%-9.91M
-61.90%6.18M
-99.68%36.43K
-99.77%11.31K
38.23%21.47M
-28.36%16.23M
-52.95%11.52M
-65.16%5.02M
-72.58%15.53M
Net profit
FPtoL-739.91K
FPtoL-223.26M
SL-92.91M
SL-67.94M
SL-33.59M
SL-164.17M
-82.40%27.59M
-78.60%32.49M
-68.61%23.28M
-87.73%39.54M
Net profit from continuing operation
97.80%-739.91K
-35.99%-223.26M
-436.73%-92.91M
-309.14%-67.94M
-244.28%-33.59M
-515.23%-164.17M
-82.40%27.59M
-78.60%32.49M
--23.28M
-87.73%39.54M
Less:Minority Profit
35.88%-2.21M
1.09%-22.46M
38.44%-11.27M
35.58%-8.26M
26.23%-3.44M
-144.31%-22.7M
-327.88%-18.31M
-2,133.81%-12.83M
-3,141.00%-4.67M
-422.83%-9.29M
Net profit of parent company owners
104.87%1.47M
-41.94%-200.8M
-277.85%-81.64M
-231.69%-59.67M
-207.86%-30.15M
-389.72%-141.47M
-71.50%45.9M
-70.26%45.31M
-62.39%27.95M
-84.71%48.83M
Earning per share
Basic earning per share
105.36%0.003
-42.31%-0.37
-287.50%-0.15
-237.50%-0.11
-212.00%-0.056
-388.89%-0.26
-73.33%0.08
-71.43%0.08
-64.29%0.05
-87.14%0.09
Diluted earning per share
105.36%0.003
-42.31%-0.37
-287.50%-0.15
-237.50%-0.11
-212.00%-0.056
-388.89%-0.26
-73.33%0.08
-71.43%0.08
-64.29%0.05
-86.96%0.09
Other composite income
-124.40%-2.63M
1,240.31%10.79M
-7,042.56%-946K
Other composite income of parent company owners
----
-124.40%-2.63M
----
----
----
1,240.31%10.79M
----
----
----
-7,042.56%-946K
Total composite income
97.80%-739.91K
-47.27%-225.89M
-436.73%-92.91M
-309.14%-67.94M
-244.28%-33.59M
-497.46%-153.39M
-82.40%27.59M
-78.60%32.49M
-68.61%23.28M
-88.02%38.59M
Total composite income of parent company owners
104.87%1.47M
-55.67%-203.43M
-277.85%-81.64M
-231.69%-59.67M
-207.86%-30.15M
-372.91%-130.68M
-71.50%45.9M
-70.26%45.31M
-62.39%27.95M
-85.00%47.88M
Total composite income of minority owners
35.88%-2.21M
1.09%-22.46M
38.44%-11.27M
35.58%-8.26M
26.23%-3.44M
-144.31%-22.7M
-327.88%-18.31M
-2,133.81%-12.83M
-3,141.00%-4.67M
-422.83%-9.29M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -14.45%340.43M-2.28%1.61B4.40%1.29B2.95%855.65M-1.10%397.92M15.23%1.65B15.59%1.23B7.13%831.15M1.82%402.33M-4.25%1.43B
Operating revenue -14.45%340.43M-2.28%1.61B4.40%1.29B2.95%855.65M-1.10%397.92M15.23%1.65B15.59%1.23B7.13%831.15M1.82%402.33M-4.25%1.43B
Other operating revenue -----13.19%12.39M----3.03%10.29M-----65.31%14.28M-----72.06%9.99M----1,459.52%41.15M
Total operating cost -19.35%347.98M9.24%1.77B14.28%1.36B15.84%914.72M15.75%431.47M28.38%1.62B32.09%1.19B28.98%789.64M20.25%372.75M11.57%1.27B
Operating cost -18.89%288.91M6.55%1.44B14.27%1.14B16.50%772.72M17.29%356.2M35.89%1.35B37.61%999.14M32.00%663.3M20.40%303.68M11.73%993.55M
Operating tax surcharges 44.28%4.78M9.33%16.66M1.99%11.45M-17.47%6.68M-19.08%3.32M4.47%15.23M-4.07%11.23M3.55%8.1M0.64%4.1M-2.49%14.58M
Operating expense -73.79%2.36M3.30%35.34M14.77%29.18M43.73%19.61M16.37%8.99M-0.83%34.21M16.67%25.42M7.33%13.64M-0.52%7.72M65.54%34.5M
Administration expense -10.10%29.33M8.85%160.32M-8.28%102.91M-9.09%68.81M-11.09%32.62M12.68%147.28M26.91%112.2M45.74%75.69M35.38%36.69M26.07%130.7M
Financial expense -38.09%6.73M12,304.42%25.88M259.68%15.69M210.08%7.27M187.22%10.87M-101.60%-212.09K-373.87%-9.83M-368.43%-6.6M4,744.50%3.78M-53.76%13.25M
-Interest expense (Financial expense) 5.69%10.81M2.27%42.03M4.92%31.54M12.29%20.77M64.96%10.22M64.92%41.1M79.91%30.06M68.62%18.5M11.01%6.2M4.98%24.92M
-Interest Income (Financial expense) 5.34%-2.34M60.10%-9.29M64.84%-6.8M70.06%-4.6M-19.45%-2.47M-42.06%-23.29M-38.21%-19.35M-56.03%-15.36M48.69%-2.07M-11.71%-16.4M
Research and development -18.50%15.87M25.83%97.45M13.81%63.5M11.61%39.64M16.11%19.48M-1.35%77.45M6.70%55.8M2.04%35.52M-11.29%16.77M2.59%78.51M
Credit Impairment Loss 41.28%-443.85K-24.68%-4.37M-73.89%-6.2M-43.52%-4.15M83.24%-755.81K-16.17%-3.51M-621.56%-3.57M-8.85%-2.89M-51.73%-4.51M5.75%-3.02M
Asset Impairment Loss ----39.69%-51.76M-25.54%-1.85M-78.43%-3.37M-----9,477.94%-85.83M-11,648,121.07%-1.48M---1.89M-----3,790.90%-896.14K
Other net revenue 4,839.37%11.65M58.76%-64.79M-222.80%-8.04M-354.49%-8.81M75.54%-245.88K-46.22%-157.09M-64.63%6.55M-74.13%3.46M-127.50%-1.01M-484.56%-107.44M
Fair value change income ----100.83%659.37K91.15%-92.58K-131.46%-1.93M-58.89%-1.2M4.82%-79.25M-162.34%-1.05M-162.35%-832.39K-156.25%-753.5K-6,477.73%-83.26M
Invest income -83.38%110.65K-338.96%-16.16M-806.75%-4.35M-1,390.71%-3.02M-19.66%665.89K92.45%-3.68M91.61%-480.21K105.38%233.66K149.66%828.79K-240.94%-48.73M
-Including: Investment income associates -----344.60%-14.23M-252.93%-2.48M-252.93%-2.48M----93.81%-3.2M---701.95K80.33%-701.95K-----243.05%-51.75M
Asset deal income -----81.32%76.3K-125.00%-7.09K-125.00%-7.09K-125.00%-7.09K795.43%408.35K148.30%28.36K-39.99%28.36K7.85%28.36K-105.78%-58.72K
Other revenue 1,043.28%11.99M-54.16%6.77M-65.87%4.47M-58.47%3.66M-69.18%1.05M-48.25%14.76M-43.36%13.09M-53.63%8.81M-50.93%3.4M-37.58%28.53M
Operating profit 112.14%4.1M-71.24%-229.39M-292.12%-86.07M-250.96%-67.89M-218.29%-33.8M-334.99%-133.95M-75.20%44.8M-74.59%44.97M-67.82%28.58M-85.27%57M
Add:Non operating Income -74.87%77.13K64.43%918.63K72.61%768.24K47.03%537.52K405.54%307K188.53%558.66K164.39%445.09K265.80%365.58K130.65%60.73K-94.20%193.62K
Less:Non operating expense 317.08%350.9K-49.52%4.7M0.44%1.43M-58.64%551.28K-74.55%84.13K337.30%9.31M6.06%1.42M62.99%1.33M36.63%330.54K-81.52%2.13M
Total profit 111.40%3.83M-63.39%-233.17M-297.90%-86.73M-254.31%-67.9M-218.63%-33.58M-359.15%-142.71M-75.58%43.82M-75.04%44M-68.05%28.31M-85.46%55.07M
Less:Income tax cost 40,276.92%4.57M-146.19%-9.91M-61.90%6.18M-99.68%36.43K-99.77%11.31K38.23%21.47M-28.36%16.23M-52.95%11.52M-65.16%5.02M-72.58%15.53M
Net profit FPtoL-739.91KFPtoL-223.26MSL-92.91MSL-67.94MSL-33.59MSL-164.17M-82.40%27.59M-78.60%32.49M-68.61%23.28M-87.73%39.54M
Net profit from continuing operation 97.80%-739.91K-35.99%-223.26M-436.73%-92.91M-309.14%-67.94M-244.28%-33.59M-515.23%-164.17M-82.40%27.59M-78.60%32.49M--23.28M-87.73%39.54M
Less:Minority Profit 35.88%-2.21M1.09%-22.46M38.44%-11.27M35.58%-8.26M26.23%-3.44M-144.31%-22.7M-327.88%-18.31M-2,133.81%-12.83M-3,141.00%-4.67M-422.83%-9.29M
Net profit of parent company owners 104.87%1.47M-41.94%-200.8M-277.85%-81.64M-231.69%-59.67M-207.86%-30.15M-389.72%-141.47M-71.50%45.9M-70.26%45.31M-62.39%27.95M-84.71%48.83M
Earning per share
Basic earning per share 105.36%0.003-42.31%-0.37-287.50%-0.15-237.50%-0.11-212.00%-0.056-388.89%-0.26-73.33%0.08-71.43%0.08-64.29%0.05-87.14%0.09
Diluted earning per share 105.36%0.003-42.31%-0.37-287.50%-0.15-237.50%-0.11-212.00%-0.056-388.89%-0.26-73.33%0.08-71.43%0.08-64.29%0.05-86.96%0.09
Other composite income -124.40%-2.63M1,240.31%10.79M-7,042.56%-946K
Other composite income of parent company owners -----124.40%-2.63M------------1,240.31%10.79M-------------7,042.56%-946K
Total composite income 97.80%-739.91K-47.27%-225.89M-436.73%-92.91M-309.14%-67.94M-244.28%-33.59M-497.46%-153.39M-82.40%27.59M-78.60%32.49M-68.61%23.28M-88.02%38.59M
Total composite income of parent company owners 104.87%1.47M-55.67%-203.43M-277.85%-81.64M-231.69%-59.67M-207.86%-30.15M-372.91%-130.68M-71.50%45.9M-70.26%45.31M-62.39%27.95M-85.00%47.88M
Total composite income of minority owners 35.88%-2.21M1.09%-22.46M38.44%-11.27M35.58%-8.26M26.23%-3.44M-144.31%-22.7M-327.88%-18.31M-2,133.81%-12.83M-3,141.00%-4.67M-422.83%-9.29M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg